Cases
Monsanto Company (NYSE: MON)
Merger
Overview
Overview
- Date:
- 11/7/2016
- Company Name:
- Monsanto Company
- Stock Symbol:
- MON
- Class Period:
- FROM 11/3/2016
- Status:
- Closed/Complete
- Court:
- U.S. District Court: Eastern Missouri
NEW YORK, November 7, 2016 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Missouri Eastern District Court on behalf of all persons or entities who held Monsanto Company (NYSE: MON) securities on November 3, 2016 (the “Class Period”).
The complaint charges Monsanto, the Company’s CEO and Chairman Hugh Grant, and the other members of the Company’s board of directors for their violations of Section 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the proposed merger between Monsanto and Bayer Aktiengesellschaft.
Pursuant to the terms of the Merger Agreement, Monsanto shareholders will receive $128.00 in cash for each share of Monsanto common stock that they own. The Merger Consideration is insufficient and undervalues the Company. Analysts have set price targets for shares of Monsanto common stock at $135.00, and the financial analyses performed by Monsanto’s financial advisor indicate the Company is worth as much as $163.00 per share.
On October 19, 2016, the Board authorized the filing of a materially incomplete and misleading Proxy Statement with the SEC, in violation of Sections 14(a) and 20(a) of the Exchange Act. In particular, the Proxy contains materially incomplete and misleading information concerning: (i) the terms and details surrounding discussions regarding alternative strategic proposals the Company received from other interested parties; (ii) financial projections for the Company; and (iii) the valuation analyses performed by the Company’s financial advisors, Morgan Stanley & Co. LLC and Ducera Securities LLC in support of their fairness opinions.
The 2016 Proxy Statement does not comply with the SEC rules and regulations, and the Court should enjoin that vote unless and until the Company discloses the material information discussed above which has been omitted from the Proxy.
If you held Monsanto securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
The complaint charges Monsanto, the Company’s CEO and Chairman Hugh Grant, and the other members of the Company’s board of directors for their violations of Section 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the proposed merger between Monsanto and Bayer Aktiengesellschaft.
Pursuant to the terms of the Merger Agreement, Monsanto shareholders will receive $128.00 in cash for each share of Monsanto common stock that they own. The Merger Consideration is insufficient and undervalues the Company. Analysts have set price targets for shares of Monsanto common stock at $135.00, and the financial analyses performed by Monsanto’s financial advisor indicate the Company is worth as much as $163.00 per share.
On October 19, 2016, the Board authorized the filing of a materially incomplete and misleading Proxy Statement with the SEC, in violation of Sections 14(a) and 20(a) of the Exchange Act. In particular, the Proxy contains materially incomplete and misleading information concerning: (i) the terms and details surrounding discussions regarding alternative strategic proposals the Company received from other interested parties; (ii) financial projections for the Company; and (iii) the valuation analyses performed by the Company’s financial advisors, Morgan Stanley & Co. LLC and Ducera Securities LLC in support of their fairness opinions.
The 2016 Proxy Statement does not comply with the SEC rules and regulations, and the Court should enjoin that vote unless and until the Company discloses the material information discussed above which has been omitted from the Proxy.
If you held Monsanto securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.